Laurence Busse, MD
Assistant Professor of Medicine
Emory University School of Medicine
2E Intensive Care Unit, Emory Saint Joseph's Hospital
Additional Contact Information
5673 Peachtree Dunwoody Road
Atlanta, GA 30342
Laurence Busse, MD completed his undergraduate and medical education at George Washington University (GWU), obtaining his MD in 2008. He trained in internal medicine at GWU from 2008-2011. After completing his residency, Dr. Busse stayed on at GWU for clinical and research fellowship training in critical care medicine from 2011-2013. After three years as an intensivist at Inova Fairfax Medical Center, he joined Emory University, where he currently serves as medical director of the medical-surgical intensive care unit at Emory Saint Joseph’s Hospital. Prior to his medical career, Dr. Busse received a masters degree in business administration from Emory in 1997, and subsequently worked as a consultant in the corporate finance departments of both PricewaterhouseCoopers and Ernst & Young.
Dr. Busse’s areas of research and interest include the examination of the sequelae of high output shock, including catecholamine-resistant hypotension and acute kidney injury. He has been involved in early clinical work exploring the use of angiotensin II as a novel therapeutic agent in catecholamine-resistant hypotension. He is actively engaged as an intensivist and, in his role as assistant professor of medicine, he supervises Emory’s pulmonary/critical care fellows in Emory Saint Joseph’s medical surgical intensive care and cardiac care units.
Dr. Busse lives with his wife, a general pediatrician, and their two children in the Atlanta area.
Busse LW, Chawla LS (Chapter) Novel Drugs for Acute Kidney Injury, Critical Care Nephrology, 3rd Edition, Ronco (Ed), - pending publication
Busse LW, Chalikonda DM, Finkel KW, Khanna AK, Szerlip HM, Xueyuan SW, Yoo D, Dana SL, Chawla LS Clinical Experience with Intravenous Angiotensin II Administration: A Systematic Review of Safety - Pending publication
Chawla LS, Busse LW, Brasha-Mitchel E, Alotaibi Z: Commentary on Intravenous Angiotensin II for the Treatment of High-Output Shock: A Safety and Dose Finding Study (ATHOS Trial), Critical Care, 2014 Oct 6;18(5):534.
Chalikonda D, Busse LW, Woo D, and Chawla LS (Abstract): Side Effects and Adverse Events Associated With Intravenous Angiotensin II in Humans: A Systematic Review and Meta-analysis, Chest, 2015, 148(4_MeetingAbstracts):348A.
Chalikonda D, Busse LW, Woo D, and Chawla LS (Poster Presentation): Side effects and adverse events associated with intravenous angiotensin II in humans: A systematic review and meta-analysis. CHEST Annual Meeting, October 2015.
Busse LW, (Chapter): Acute Kidney Injury in the Intensive Care Environment, Adult Multiprofessional Critical Care Review. Pastores, SM (Ed), Society of Critical Care Medicine, September 2015: Available in epub format at www.sccm.org.
Busse LW, Davison D, Chawla L (Chapter): Hemodynamic Monitoring in Critical Care, Diet and Nutrition in Critical Care, Reedy V (Ed), Kings College London, July 2015.
Reviewer, "Interhospital Transfers: An Analysis of Patients Transferred to a Tertiary Oncologic ICU " by Kamat et al. Am J Crit Care. 2015 May; 24(3):241-7.
Chawla LS, Busse LW, Brasha E, Davison DL, Honig J, Alotaibi ZK, Seneff MG: Intravenous Angiotensin II for the Treatment of High-Output Shock: A Safety and Dose Finding Study (ATHOS Trial) Critical Care, 2014 Oct 6;18(5):534.
Busse LW, Hawkins K, Chawla LS (Chapter): The Perioperative Management of the Patient with Chronic Kidney Disease, Chronic Renal Disease, Kimmel P (Ed), 2015 Elsevier.
Busse LW, Vourlekis J (Review Article): Submassive Pulmonary Embolism, Critical Care Clinics, 2014 Jul;30(3):447-73.
Busse LW (Poster Presentation): Angiotensin II may be useful for the treatment of hypotension in distributive shock, but a safe and efficacious dose is unknown. 34th International Symposium on Intensive Care and Emergency Medicine, March, 2014, Brussels.
Busse LW, Brasha E, Davison DL, Seneff MG, Honig J, Alotaibi ZK, Chawla LS (Abstract): Angiotensin II may be useful for the treatment of hypotension in distributive shock, but a safe and efficacious dose is unknown. Critical Care, March 2014 meeting abstracts.
Busse LW (Oral Presentation): A Case of Refractory Shock, Morbidity and Mortality Conference, Medical Critical Care Service, Department of Medicine, Inova Health System, April 2013.
Busse L, Chawla L, Panchamia R, Choi D, Nobakht E, Brasha-Mitchell E, Seneff M (Abstract): Strong ion gap can be accurately estimated with a simple bedside equation, Critical Care 2013, 17(Suppl 2):P444.
Busse LW (Poster Presentation): The strong ion gap can be accurately estimated with a simple bedside equation, 33rd International Symposium on Intensive Care and Emergency Medicine, March 20, 2013, Brussels.
Busse L, Chawla, L (Review Article): Hemodynamic monitoring in the critical care environment, Advances in Chronic Kidney Disease. Volume 20(1), 2013.
Busse L, Chawla L (Chapter): Acute Kidney Injury in the Intensive Care Environment, Adult Multiprofessional Critical Care Review. Szalados JE, Rehm CG (Eds), Society of Critical Care Medicine, 2012: 143-157.
Busse L, Chawla L, Panchamia R, Choi D, Nobakht E, Brasha-Mitchell E, Seneff M (Abstract): Minding the Gap: A Comparison of the Albumin-Lactate-Phosphate Corrected Anion Gap (ALPCAG) to the Strong Ion Gap (SIG), CHEST. 2011;140 (4 – Meeting Abstracts):1012A-1012A.
Busse LW (Oral Presentation): Minding the Gap: Testing a Short-Cut Equation to Approximate the Strong Ion Gap in Critically Ill Patients, CHEST, October 2011.
Busse LW (Oral Presentation): A Woman with Altered Mental Status and Diabetes Insipidus, Clinical Pathology Conference, Department of Internal Medicine, George Washington University, April 28, 2010.